Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-25 Purchase |
2022-05-27 4:10 pm |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I CHIEF EXECUTIVE OFFICER |
2,482 | $2.58 | $6,404 | 232,558 (Indirect Direct) |
View |
| 2022-05-19 Purchase |
2022-05-23 4:41 pm |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I CHIEF EXECUTIVE OFFICER |
13,256 | $2.7938 | $37,034 | 230,076 (Indirect Direct) |
View |
| 2022-05-19 Purchase(A) |
2022-05-23 4:00 pm |
Gain Therapeutics Inc. | GANX | Calabrese Salvatore CHIEF FINANCIAL OFFICER |
3,000 | $2.7 | $8,100 | 3,000 (Direct) |
View |
| 2022-05-19 Purchase(M) |
2022-05-19 5:00 pm |
Gain Therapeutics Inc. | GANX | Calabrese Salvatore CHIEF FINANCIAL OFFICER |
3,000 | $2.7 | $8,100 | 8,100 (Direct) |
View |
| 2021-08-16 Purchase(A) |
2022-04-21 4:50 pm |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Chief Executive Officer |
4,922 | $7.866 | $38,716 | 216,820 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-20 Option Award |
2022-09-22 4:10 pm |
N/A 2032-09-20 |
Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2022-09-20 Option Award |
2022-09-22 4:09 pm |
N/A 2032-09-20 |
Gain Therapeutics Inc. | GANX | Melincoff Gwen A Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2022-09-20 Option Award |
2022-09-22 4:08 pm |
N/A 2032-09-20 |
Gain Therapeutics Inc. | GANX | Nicaise Claude Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2022-09-20 Option Award |
2022-09-22 4:07 pm |
N/A 2032-09-20 |
Gain Therapeutics Inc. | GANX | HASLER HANS PETER Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2022-09-20 Option Award |
2022-09-22 4:06 pm |
N/A 2032-09-20 |
Gain Therapeutics Inc. | GANX | Alder Matthias Chief Operating Officer |
71,100 | $0 | 71,100 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 4:37 pm |
N/A 2032-07-15 |
Gain Therapeutics Inc. | GANX | Calabrese Salvatore Chief Financial Officer |
69,300 | $0 | 69,300 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 4:36 pm |
N/A 2032-07-15 |
Gain Therapeutics Inc. | GANX | Alder Matthias Chief Operating Officer |
92,400 | $0 | 92,400 (Direct) |
View |
Ownership(A) |
2022-04-21 4:47 pm |
N/A 2030-12-15 |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Chief Executive Officer |
0 | $0 | 26,424 (Direct) |
View |
| 2021-12-23 Option Award |
2021-12-28 4:30 pm |
2022-10-15 2032-10-15 |
Gain Therapeutics Inc. | GANX | Alder Matthias CHIEF OPERATING OFFICER |
200,000 | $5.86 | 200,000 (Direct) |
View |
| 2021-08-16 Exercise |
2021-08-17 9:03 pm |
N/A N/A |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director |
4,922 | $7.866 | 216,820 (Direct) |
View |
Ownership |
2021-03-29 8:38 pm |
N/A 2030-09-24 |
Gain Therapeutics Inc. | GANX | Bellotto Manolo President and General Manager |
0 | $0 | 123,309 (Direct) |
View |
Ownership |
2021-03-29 8:34 pm |
N/A 2030-09-24 |
Gain Therapeutics Inc. | GANX | Calabrese Salvatore Chief Financial Officer |
0 | $0 | 83,674 (Direct) |
View |
Ownership |
2021-03-29 7:44 pm |
N/A 2031-01-22 |
Gain Therapeutics Inc. | GANX | Riley Jeffrey Scott Director |
0 | $0 | 10,000 (Direct) |
View |
Ownership |
2021-03-29 7:41 pm |
N/A 2031-01-22 |
Gain Therapeutics Inc. | GANX | HASLER HANS PETER Director |
0 | $0 | 10,000 (Direct) |
View |
Ownership |
2021-03-17 8:54 pm |
N/A 2031-01-22 |
Gain Therapeutics Inc. | GANX | Melincoff Gwen A Director |
0 | $0 | 10,000 (Direct) |
View |
Ownership |
2021-03-17 8:52 pm |
N/A 2031-01-22 |
Gain Therapeutics Inc. | GANX | Nicaise Claude Director |
0 | $0 | 10,000 (Direct) |
View |
Ownership |
2021-03-17 8:49 pm |
N/A N/A |
Gain Therapeutics Inc. | GANX | Islam Khalid Director |
0 | $0 | 905,784 (Indirect) |
View |
Ownership |
2021-03-17 8:46 pm |
N/A N/A |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Chief Executive Officer |
0 | $0 | 211,898 (Direct) |
View |
Ownership |
2021-03-17 8:43 pm |
N/A 2031-01-22 |
Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director |
0 | $0 | 10,000 (Direct) |
View |